The Global In Vivo CRO Market is driven by increasing R&D activities in pharmaceutical and biotechnology industries

Comments · 16 Views

The Global In vivo CRO Market is estimated to be valued at US$ 4.70 billion in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024-2031.

The in vivo CRO market involves contract research organizations that conduct animal testing and experiments for pharmaceutical, biotechnology, medical device, chemical, and other associated industries. In vivo CROs help sponsors in evaluating the safety and efficacy of drugs, vaccines, and medical devices intended for use in humans.

 

In Vivo CRO Market Demand for new drugs and medical devices from the pharmaceutical and biotech industries is driving the need for specialized in vivo testing services. Stringent regulations have also made sponsors rely more on contract research organizations for data generation in the preclinical development phase.

In vivo testing is important to understand how a new drug behaves inside a living system and to identify any adverse effects before commencing expensive human clinical trials. The global in vivo CRO market saw significant growth over the past few years owing to rising R&D investments by pharmaceutical companies and growing government support for medical research.

 

Get more insights on, In Vivo CRO Market

 

Explore More Related Article On- Antidepressant Market



Comments